Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

QS Stock: QuantumScape Shares Charge Up on Big Apple EV News

By Robert Lakin, InvestorPlace Contributor

QS stock is climbing higher Tuesday on reports that Apple is working on an iCar. Here's what you need to know right now.

EYEG Stock: Why EyeGate Pharma Is Up More Than 80% Today

By Robert Lakin, InvestorPlace Contributor

EyeGate Pharma shares doubled on Monday morning following the news of its acquisition of Austria's Panoptes Pharma. Zacks earlier boosted its target on EYEG stock to $15 a share.

PIC Stock: Pivotal Shares Soar Ahead of XL Fleet SPAC Merger Vote

By Robert Lakin, InvestorPlace Contributor

PIC shareholders vote today on the merger with electric vehicle maker XL Fleet, in the latest SPAC IPO that is fueling EV fund raising. But investors shouldn't think they've missed the boat.

Cruise Stocks: Why NCLH, RCL and CCL Stock Are Sinking Today

By Robert Lakin, InvestorPlace Contributor

Cruise stocks had begun to see a light at the end of the tunnel. But a new virus variant is disrupting travel and shaking markets, pushing down CCL stock in pre-market.

XSPA Stock: Why Covid-19 Play XpresSpa Is Soaring Today

By Robert Lakin, InvestorPlace Contributor

XSPA stock is soaring Thursday on news that XpresSpa just landed another Covid-19 testing deal with United Airlines. Here's why it matters.

Load More